For instance, research shows that the levels of TMEM16A mRNA and protein are significantly elevated in metastatic prostate cancer cell lines, including LNCaP and PC-3, as confirmed by quantitative PCR, Western blotting, and patch clamp assays (Liu et al., 2012). The gene discussed is ANO1; the disease is Familial prostate cancer.